The U.S. Securities and Exchange Commission’s investigation into Cardinal Health Inc.’s Executive Chairman of the Board, as well as four former officers and employees, is ongoing.
On Oct. 7, 2003, the Company received a request from the SEC relating to…
Cardinal Health Inc. continues cooperating with the state attorney general offices of Illinois and New York regarding their investigations into a program on repackaged pharmaceuticals.
In October 2005, the Company received a subpoena from the Attorney General’s Office of the State…
Cardinal Health Inc., during the quarter ended June 30, 2008, received the remaining US$35.0 million in net proceeds from the settlement of the derivative actions filed against the Company and certain of its directors and officers.
On Nov. 8, 2002,…
Cardinal Health Inc. and the Drug Enforcement Administration of the U.S. Department of Justice, on Aug. 7, 2008, reached an oral agreement in principle to resolve the license suspensions.
The agreement is subject to the completion of definitive documentation as…